Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells - PubMed (original) (raw)
Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells
Rhian M Touyz et al. J Hypertens. 2004 Jun.
Abstract
Objective: The role of reactive oxygen species (ROS) in mitogen-activated protein kinase (MAPK) signaling by angiotensin (Ang) II and endothelin-1 (ET-1) in human vascular smooth muscle cells (VSMC) was investigated.
Design: VSMCs were derived from resistance arteries from healthy subjects. MAPK activity was assessed using phospho-specific antibodies. ROS generation was measured by CMH2DCFDA fluorescence and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity by lucigenin chemiluminescence.
Results: Ang II and ET-1 increased MAPK phosphorylation (P < 0.01). Pre-treatment with Tiron and Tempol, *O2 scavengers, attenuated agonist-stimulated phosphorylation of p38MAPK, c-Jun N-terminal kinases (JNK) and ERK5, but not of ERK1/2 (extracellular signal-regulated kinases). Apocynin and diphenylene iodinium (DPI), NAD(P)H oxidase inhibitors, decreased Ang II-induced responses 60-70%. ET-1-mediated MAPK phosphorylation was unaffected by apocynin but was reduced (> 50%) by thenoyltrifluoroacetone (TIFT) and carboxyl cyanide-m-chlorophenylhydrazone (CCCP), mitochondrial inhibitors. Allopurinol and N-nitro-l-arginine methyl ester (l-NAME), xanthine oxidase and nitric oxide synthase (NOS) inhibitors, respectively, did not influence MAPK activation. Intracellular ROS generation, was increased by Ang II and ET-1 (P < 0.01). DPI inhibited Ang II- but not ET-1-mediated ROS production. Expression of p22phox and p47phox and activation of NAD(P)H oxidase were increased by Ang II but not by ET-1. CCCP and TIFT significantly attenuated ET-1-mediated ROS formation (P < 0.05), without influencing Ang II effects.
Conclusions: Ang II activates p38MAPK, JNK and ERK5 primarily through NAD(P)H oxidase-generated ROS. ET-1 stimulates these kinases via redox-sensitive processes that involve mitochondrial-derived ROS. These data suggest that redox-dependent activation of MAPKs by Ang II and ET-1 occur through distinct ROS-generating systems that could contribute to differential signaling by these agonists in VSMCs.
Similar articles
- Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL. Touyz RM, et al. Can J Physiol Pharmacol. 2003 Feb;81(2):159-67. doi: 10.1139/y02-164. Can J Physiol Pharmacol. 2003. PMID: 12710530 - Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kübler W, Kreuzer J. Viedt C, et al. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):940-8. doi: 10.1161/01.atv.20.4.940. Arterioscler Thromb Vasc Biol. 2000. PMID: 10764657 - Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.
Bruder-Nascimento T, Chinnasamy P, Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC, Sibinga NE. Bruder-Nascimento T, et al. J Mol Cell Cardiol. 2014 Jan;66:18-26. doi: 10.1016/j.yjmcc.2013.10.013. J Mol Cell Cardiol. 2014. PMID: 24445059 Free PMC article. - Redox signaling in hypertension.
Paravicini TM, Touyz RM. Paravicini TM, et al. Cardiovasc Res. 2006 Jul 15;71(2):247-58. doi: 10.1016/j.cardiores.2006.05.001. Epub 2006 May 9. Cardiovasc Res. 2006. PMID: 16765337 Review. - Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.
Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM. Nguyen Dinh Cat A, et al. Antioxid Redox Signal. 2013 Oct 1;19(10):1110-20. doi: 10.1089/ars.2012.4641. Epub 2012 Jun 11. Antioxid Redox Signal. 2013. PMID: 22530599 Free PMC article. Review.
Cited by
- Endothelin Receptor A Antagonism Prevents Damage to Glycogen-Rich Placental Cells Following Uterine Ischemia-Reperfusion in the Rat.
Thaete LG, Khan S, Neerhof MG. Thaete LG, et al. Reprod Sci. 2016 Nov;23(11):1518-1525. doi: 10.1177/1933719116645190. Epub 2016 Apr 28. Reprod Sci. 2016. PMID: 27130231 Free PMC article. - Vascular inflammation and endothelial dysfunction in experimental hypertension.
Savoia C, Sada L, Zezza L, Pucci L, Lauri FM, Befani A, Alonzo A, Volpe M. Savoia C, et al. Int J Hypertens. 2011;2011:281240. doi: 10.4061/2011/281240. Epub 2011 Sep 11. Int J Hypertens. 2011. PMID: 21915370 Free PMC article. - Redox signaling, Nox5 and vascular remodeling in hypertension.
Montezano AC, Tsiropoulou S, Dulak-Lis M, Harvey A, Camargo Lde L, Touyz RM. Montezano AC, et al. Curr Opin Nephrol Hypertens. 2015 Sep;24(5):425-33. doi: 10.1097/MNH.0000000000000153. Curr Opin Nephrol Hypertens. 2015. PMID: 26197203 Free PMC article. Review. - Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca²⁺]i in mesenteric microvessels of pregnant rats.
Mazzuca MQ, Dang Y, Khalil RA. Mazzuca MQ, et al. Br J Pharmacol. 2013 Jul;169(6):1335-51. doi: 10.1111/bph.12225. Br J Pharmacol. 2013. PMID: 23646960 Free PMC article. - Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. McCubrey JA, et al. Biochim Biophys Acta. 2007 Aug;1773(8):1263-84. doi: 10.1016/j.bbamcr.2006.10.001. Epub 2006 Oct 7. Biochim Biophys Acta. 2007. PMID: 17126425 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous